Alopecia Areata and Atopic Dermatitis
NOVEMBER 2021 | ISDS Meeting 2021
PROGRAM CHAIRS
Emma Guttman, MD PhD
International Eczema Council, Immediate Past-President
Icahn School of Medicine at Mount Sinai, New York, NY, USA
 Natasha A. Mesinkovska, MD, PhD
National Alopecia Areata Foundation, Chief Science Officer
University of California, Irvine, CA, USA
 Julie K. Block
National Eczema Association, President and CEO
Novato, CA, USA
Sessions include:
- Pathogenesis of AD and Relevance to Alopecia Areata | Emma Guttman, MD, PhD | New York, NY
- Pathogenesis of Alopecia Areata | Natasha Mesinkovska, MD, PhD | Irvine, CA
- Epidemiology of Alopecia Areata and Atopic Comorbidities | Jonathan Silverberg, MD, MPH, PhD | Washington, D.C.
- Novel treatments of atopic dermatitis (focus on biologics) | Lawrence Eichenfield, MD | San Diego, CA
- Clinical Trails Awareness for the Eczema Community | Wendy Smith-Begolka, MBS | Novato, CA
- Alopecia Areata: Other Emerging Treatment Options | Jerry Shapiro, MD | New York, NY
- Pediatric Alopecia Areata and Role of Atopy | Leslie Castelo-Soccio, MD, PhD | Philadelphia, PA
- JAK inhibitors across AD and alopecia areata | Brett King, MD, PhD | New Haven, CT
|
